VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $28,991,578,000 | +193.9% | 1,821,079 | +283.6% | 0.06% | +205.6% |
| Q4 2017 | $9,865,637,000 | +161.5% | 474,766 | +95.5% | 0.02% | +100.0% |
| Q3 2017 | $3,773,392,000 | -74.4% | 242,851 | -70.3% | 0.01% | -79.5% |
| Q2 2017 | $14,764,050,000 | +34.5% | 816,625 | -17.1% | 0.04% | +51.7% |
| Q1 2017 | $10,976,290,000 | -28.6% | 985,526 | -5.4% | 0.03% | -59.7% |
| Q4 2016 | $15,377,599,000 | -30.2% | 1,041,706 | +16.1% | 0.07% | -20.9% |
| Q3 2016 | $22,032,643,000 | +151.9% | 897,460 | +106.6% | 0.09% | +133.3% |
| Q2 2016 | $8,747,265,000 | -9.1% | 434,323 | +18.6% | 0.04% | -4.9% |
| Q1 2016 | $9,627,273,000 | -83.3% | 366,056 | -35.6% | 0.04% | -70.7% |
| Q4 2015 | $57,799,819,000 | +302.3% | 568,616 | +605.9% | 0.14% | +288.9% |
| Q3 2015 | $14,368,152,000 | +156.6% | 80,548 | +219.6% | 0.04% | +125.0% |
| Q2 2015 | $5,599,513,000 | +571.7% | 25,206 | +500.6% | 0.02% | +700.0% |
| Q1 2015 | $833,608,000 | +6.5% | 4,197 | -23.2% | 0.00% | -33.3% |
| Q4 2014 | $782,382,000 | -7.5% | 5,467 | -14.9% | 0.00% | +200.0% |
| Q3 2014 | $845,878,000 | -73.6% | 6,421 | -73.3% | 0.00% | -66.7% |
| Q2 2014 | $3,209,491,000 | -40.2% | 24,026 | -36.7% | 0.00% | -25.0% |
| Q1 2014 | $5,367,715,000 | +592.8% | 37,962 | +475.2% | 0.00% | – |
| Q4 2013 | $774,840,000 | – | 6,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |